Masters Thesis 2003

20
Expression of Cyclin D1, p27 and p21 in MCF-7 cells treated with 4-OH Tamoxifen in the presence of growth factors Anna Merca Department Of Oncology Division of Biomedicine and Surgery Faculty of Health Sciences Linköping University

description

Expression of Cyclin D1, p27 and p21 in MCF-7 cells treated with 4-OH Tamoxifen in the presence of growth factors Linköping University

Transcript of Masters Thesis 2003

  • 1. Expression of Cyclin D1, p27 and p21 in
    MCF-7 cells treated with 4-OH
    Tamoxifen in the presence
    of growthfactors
    Anna Merca
    Department Of Oncology
    Division of Biomedicine and Surgery
    Faculty of Health Sciences
    Linkping University

2. Aims of the Study
General Aim:
To determine the effect of 4-OH Tamoxifen (4-OH TAM) on cell cycle regulators in MCF-7 cellsin the presence of growth factors such as heregulin1(HRG1) and/or estradiol (E2).
Specific Aim:
To determine the expression of Cyclin D1, p27 Kip1 and p21 Waf1/CIP1 in MCF-7 cells.
3. Estrogen
4. Tamoxifen (TAM)
5. SERM-ER
promoter
Gene Activation
(charged SERM-ER complex)
Gene Silent
(neutral SERM-ER complex)
Estrogenic
Anti-estrogenic
Surface Signaling
EGFR
HER2/neu
TKs
Phosphorylation Cascade
CoR
CoA
CoA
CoR
AF-2b
AF-2b
AF-1
AF-1
SERM-ER
promoter
6. Cyclin B
cdc2
Cyclin D1
cdk4/6
P
Cyclin A
Cyclin A
pRB
Cyclin E
cdk2
cdc2
E2F
cdk2
pRB
P
(early G1)
G0
G1
M
p21
p27
G2
S
(late G1 )
E2F
The Cell Cycle
7. Material
MCF-7 cells
8. Methods
Cell Lysis
SDS- PAGE + Western Blotting
Vindelv Method for Cell Cycle Analysis
9. Control 4-OH TAM
1M4 M
- Estradiol
+Estradiol (1nM)

  • Heregulin 1

(50ng/ml)
- Estradiol
+Estradiol (1nM)
+ Heregulin 1
(50ng/ml)
10. 4-OH TAM1M-+ - -+ -- + - -+ -
4-OH TAM4M- -+ - - + - -+- - +
E2 1nM- - - ++ + - --+ ++
HRG110ng/ml -- - - -- ++++++
24h
48h
72h
Results
Cyclin D1 expression in MCF-7 cells treated with
4-OH TAM, +/- E2, +/- HRG1
11. 4-OH TAM1M-+ - -+ -- + - -+ -
4-OH TAM4M- -+ - - + - -+- - +
E2 1nM - - - ++ + - --+ ++
HRG110ng/ml-- - - -- ++++++
24h
48h
72h
Results
p21 Waf1 expression in MCF-7 cells treated with
4-OH TAM, +/- E2, +/- HRG1
12. 4-OH TAM1M-+ - -+ -- + - -+ -
4-OH TAM4M- -+ - - + - -+- - +
E21nM- - - ++ + - --+ ++
HRG1 10ng/ml-- - - -- ++++++
24h
48h
72h
Results
p27 Kip expression in MCF-7 cells treated with
4-OH TAM, +/- E2, +/- HRG1
13. 4-OH TAM1M-+ - -+ -- + - -+ -
4-OH TAM4M- -+ - - + - -+- - +
E2 1nM- - - ++ + - --+ ++
HRG1 10ng/ml-- - - -- ++++++
24h
48h
72h
Results
Beta Actin expression in MCF-7 Cells treated with 4-OH TAM, +/- E2, +/- HRG1
14. 15. 16. 17. P
Cyclin D1
pRB
E2F
Cyclin D1
Cdk4
DNA
pRB
P
Cell Cycle Regulation
E2
E2F
MCF-7 cells
18. Cyclin B
cdc2
Cyclin D1
cdk4/6
P
Cyclin A
Cyclin A
pRB
Cyclin E
cdk2
cdc2
E2F
cdk2
pRB
P
G0
(early G1)
G1
M
p21
p27
G2
S
(late G1 )
E2F
Cell CycleRegulation
19. Conclusions
HRG1-stimulated expression of Cyclin D1 and p21 in MCF-7 cells wasunaffected by addition of E2 and/or 4-OH TAM.
E2-induced increase in expression of Cyclin D1 wasobserved in all treatment periods (24, 48, and 72h), addition of 4-OH TAM attenuated CyclinD1 levels.
E2-induced increase in expression of p27 wasobservedonly after 48 and 72h treatment periods.
HRG1-stimulated expression of p27 was not affected by addition of 4-OH TAM at 48 and 72h.
Addition of E2 to HRG1 attenuated the levels of p27 at 48 and 72h treatments.
Addition of 4-OH TAM in increasingconcentration to all treatmentslessened the percentage of cells going to S-phase of the cell cycle.
20. Future Experiments
To confirm the current results:
repeat western blots on Cyclin D1, p27, and p21,
repeat the Vindelv Method for Cell Cycle Analysis,
Additional Experiments:
determine Cyclin E expression by western blotting
assess apoptosis using M30 antibody